Blue Ridge Partners/Insights/Growth strategy/First 90 Days in Commercial AI: How to Prioritize and Sequence AI Investments

First 90 Days in Commercial AI: How to Prioritize and Sequence AI Investments

Most Commercial AI initiatives fail before they ever scale — not because the technology doesn’t work, but because Commercial AI initiatives are sequenced incorrectly. In private equity portfolio companies and mid-market commercial organizations, AI is often treated like a technology rollout. In reality, it is a strategic commercial redesign that needs to start off on the right foot from Day One.

The uncomfortable truth is this: most AI spend fails to pay off when organizations assume the technology alone will drive performance. Promising tools get deployed, dashboards get built, pilots get turned on — but without fine-tuning the workflows that impact revenue. As a result, revenue growth remains unchanged, and AI initiatives end up as sizable cost centers. Recent market data reinforces this reality: only 13% of Commercial AI tools and Commercial AI-enabled processes deployed today are generating meaningful ROI. Most organizations are investing, but not translating that investment into revenue impact.

Closing that gap begins with sequencing discipline, and the foundational first 90 days of any Commercial AI program are the most important. This guide outlines a practical, sequenced AI implementation roadmap for CEOs and Operating Partners who want to maximize Commercial AI ROI in the critical first three months — particularly in private equity portfolio companies where value creation timelines and expectation management are of critical importance.

Why the First 90 Days Matter for Commercial AI Strategy

Commercial AI outcomes are path-dependent, and companies that treat AI as experimentation spend the first 90 days (and beyond) chasing tools. However, premature tool selection skews workflow design, poor internal alignment locks in technical debt, overspending occurs before readiness is confirmed, and governance gaps compound. Therefore, proper Commercial AI sequencing is critical.

The companies that successfully avoid the Commercial AI execution gap do not begin by throwing money or technology at problems — they treat AI as a commercial transformation and spend the first 90 days clarifying bottlenecks. Specifically, they begin by:

  • Deeply understanding core workflows before layering in automation
  • Identifying the primary bottleneck constraining growth rather than deploying broad, unfocused solutions
  • Aligning initiatives to a clearly defined enterprise-value metrics
  • Launching narrow, execution-oriented pilots tied to measurable outcomes
  • Establishing governance structures from the outset to ensure adoption and accountability

Executional AI beats experimental AI, but only when the foundation is right.

By thoughtfully diagnosing, prioritizing, and sequencing their first 90 days of action, commercial leaders establish early Commercial AI focus on the areas where AI can materially shift enterprise value. This discipline separates durable AI value creation plans from stalled pilots.

Companies that successfully sequence their first 90 days position themselves to reach a Commercial AI inflection point—the moment where AI investments begin compounding into measurable revenue and EBITDA impact. Before this point, AI feels experimental. After it, AI becomes a repeatable value creation lever embedded within the commercial engine.

In private equity portfolio companies, this distinction is further amplified. AI in PE-backed companies is often positioned as a fast lever for revenue growth. However, when the sequencing is wrong, AI becomes a cost without lift — increasing tech stack complexity without improving win rates, customer retention, margin realization, or sales rep productivity.

Days 1-30: Diagnose Workflow Bottlenecks

AI delivers measurable impact only when applied to the specific decision points and workflow bottlenecks that drive revenue — not when deployed broadly across loosely defined experimentation efforts.

Therefore, with proper Commercial AI sequencing and focus in mind, the objective for the first 30 days is simple: identify the primary commercial constraint that’s limiting growth.

Here’s how to get there:

Step 1: Map Core Commercial Workflows

Before discussing tools, CEOs, Operating Partners, and teams must clearly map out how revenue is actually being generated. This includes:

  • Pipeline creation
  • Opportunity qualification
  • Deal progression
  • Account planning
  • Pricing decisions
  • Renewal management

This exercise often reveals something unsettling: workflows exist in theory, but not in practice. Sales stages can be too loosely defined, account planning varies by rep, pricing decisions are discretionary, and client renewal strategies are overly reactive.

Layering AI onto loose or inconsistent workflows simply magnifies the chaos. Therefore, effective Commercial AI strategy must begin with workflow documentation and smart workflow redesign to create greater clarity.

Step 2: Identify Variability

AI for sales and marketing improvement delivers value when it successfully reduces performance variability — because variability often reveals your bottlenecks. To gauge existing variability in your commercial organization, ask:

  • Where are performance distributions the most pronounced?
  • Which reps consistently outperform their peers?
  • Where is decision-making inconsistent?
  • Where do deals stall?
  • Where do discounts spike?

Commercial AI strategy isn’t about automation volume — it’s about stabilizing high-variance decisions that materially affect revenue. Look for wide performance distributions across the organization, such as win rates swinging 20% by rep or region, discounting that varies wildly by manager, or renewal success rates that seem to depend on informal, undocumented knowledge and processes.

Step 3: Assess Data Readiness

A Commercial AI value creation plan must be measurable in order to determine its impact. And measurement relies on having robust, high-quality data processes in place.

The AI readiness assessment for commercial organizations must be pragmatic. Commercial and IT teams should be honest and realistic with one another when asking:

  • Is CRM data up-to-date and trusted?
  • Are sales stages enforced?
  • Can we measure win rate by segment?
  • Are pricing decisions logged consistently?
  • Can we isolate rep-level productivity?

If you cannot visualize or measure a workflow, it’s not a good starting place for AI.

This is where many AI implementation roadmaps stall — not because the AI is immature, but because data or process discipline is weak. Before scaling AI for sales and marketing growth, pause to ensure your commercial data systems and processes can support it.

Leading organizations assess readiness across four dimensions:

  • Data & Process Readiness: Data quality, governance, and workflow consistency
  • Integration Readiness: CRM, financial systems, and third-party data connectivity
  • Execution Discipline: Ability to prioritize, pilot, and drive adoption
  • Operating Model: Cross-functional alignment and ownership

Weakness in any of these areas will limit AI impact regardless of tool sophistication.

Step 4: Align on the “Killer Metric”

To demonstrate clear Commercial AI ROI, AI value creation plans must tie to an enterprise-value metric that has been agreed upon across the organization. The chosen “killer metric” should align with the current priorities of the commercial team, and could be:

  • Win rate improvement
  • Customer retention lift
  • Margin realization
  • Sales rep productivity
  • Account growth/upsell

Without a killer metric as your North Star, AI becomes little more than innovation theater.

For AI initiatives in private equity portfolio companies, this alignment should map directly to underwriting assumptions and EBITDA expansion priorities.

Days 30-60: Select One Executional AI Use Case

With optimized workflows, a clear target bottleneck, verified data readiness, and a chosen killer metric, it’s time to move on to execution planning. The objective for Days 30-60 is to choose one executional AI use case that’s directly tied to the bottleneck and killer metric identified in Month 1.

What Executional AI Means

Executional AI is a revenue-impacting AI use case successfully moved from idea to action. While experimental AI often distracts from revenue performance, executional AI compounds it. To be considered executional AI, an initiative must:

  • Impact revenue levers directly
  • Integrate into core business workflows
  • Be measurable within 6 months
  • Have a clear owner

Empirical Commercial AI performance data shows that initiatives tied directly to revenue levers — such as win rate improvement, margin realization, or sales rep productivity — materially outperform unfocused AI deployments. Consider the following examples of experimental AI vs. executional AI:

Experimental AIExecutional AI
Generic chatbot deployment for account researchPredictive targeting models for account prioritization
Sales enablement content creation and simulated training with generic avatarsDeal-level and rep-specific training and coaching
Broad data enrichment automation“Just in time” ICP and persona-specific enrichment 

Experimental AI sits on the periphery, while executional AI sits inside actual revenue workflows.

Companies driving the most Commercial AI value don’t run more pilots—they run more focused ones. High-performing organizations concentrate on a small number of high-impact metrics, while low-performing ones spread effort across too many initiatives without measurable outcomes.

Executional AI Use Case Selection Criteria

Before greenlighting a pilot, confirm that the chosen executional AI use case conforms to the following criteria:

  1. Will directly impact the identified bottleneck
  2. Has sufficient data availability and/or workflow visibility for a meaningful pilot
  3. Has a clear owner
  4. Has defined success metrics, including a fully-aligned killer metric

If you can’t place a check mark next to each of these four criteria, then you are not yet ready to pilot. This disciplined pragmatism and focus is central to effective GTM AI strategy, and avoids the fragmented pilots that often plague Commercial AI in private equity portfolio companies.

For deeper benchmarking data on how Commercial AI initiatives perform across PE-backed companies, explore our Commercial AI research and data insights.

Days 60-90: Pilot, Instrument, and Build Governance

Having selected one specific executional AI use case, the objective for Days 60-90 is to move that executional AI use case from idea to action. Here’s how:

Step 1: Pilot Narrow & Deep

The most effective pilots follow a “narrow and deep” approach—focusing on a tightly defined group, workflow, and metric. In contrast, while “wide and thin” pilots are visible to theatregoers, they rarely deliver the level measurable impact that serious investors expect.

Instead, select a pilot group that’s well-defined and controlled:

  • One region
  • One customer segment
  • One team

Be sure to define usage expectations with involved parties to clarify when and how the Commercial AI tool or AI-enabled process should be used. This can have a big impact on measurement success later on.

Step 2: Instrument the Workflow

Instrumentation converts AI from advisory to accountability. Build prescriptive workflows around the executional AI use case, and define measurable outcomes tied to your killer metric. These could include:

  • Win rate change
  • Rep productivity shift
  • Discount reduction
  • Pipeline quality improvement
  • Time-to-close reduction

Commercial AI for revenue growth must ultimately connect to value creation. Therefore, wherever possible, translate performance changes into EBITDA impact.

Step 3: Establish Governance Early

Most Commercial AI programs fail at getting this step right. But governance failures consistently widen the execution gap, leaving AI insights disconnected from compliance policies and expectations. Governance isn’t bureaucracy — it’s security, reinforcement, and peace of mind.

An effective AI governance plan in commercial organizations must include:

  • Manager inspection cadence
  • Clear workflow documentation
  • Incentive alignment
  • Data hygiene enforcement
  • Ownership of performance tracking

With proper governance in place, Commercial AI becomes institutional rather than merely advisory.

What to Aim For (and Avoid) in the First 90 Days in Commercial AI

By executing on the above steps, after 90 days commercial organizations will have developed a solid Commercial AI foundation that has put them in a good position to cross the Commercial AI Inflection Point. They also will have avoided some common missteps that hurt many AI implementation roadmaps.

What Good Looks Like After 90 Days

With the disciplined Commercial AI sequencing outlined in this guide, by Day 90 your commercial organization should have:

  • A clear diagnosis of your primary bottleneck(s)
  • A completed AI readiness assessment, with identified gaps filled in
  • An internally-aligned killer metric (and other defined success metrics)
  • One executional AI use case pilot live
  • A detailed governance framework in place
  • A roadmap for scaling AI based on results

A strong example of this is illustrated by a Blue Ridge Partners client in the Business Services industry. By working with the client we identified their primary bottlenecks as opportunity conversion rate and deal size. The client implemented a controlled Commercial AI pilot to impact their “killer metrics” of MQL:SQL conversion and ACV, and achieved a 8-10X improvement in these metrics after the program had been live for 90 days.

Leading organizations are already demonstrating what effective sequencing can achieve:

  • AI-Driven Targeting (Business Services)
    • 10x increase in SQLs within 3 months
    • 8x+ higher ACV on targeted accounts
    • +63% increase in average deal size
  • AI-Enabled Seller Enablement (SaaS Roll-Up)
    • +25% increase in average deal size
    • 107% of annual growth target achieved
  • AI-Enabled GTM Transformation (Enterprise SaaS)
    • +30% revenue growth
    • +102% LTV:CAC improvement
    • -36% commercial costs

In each case, success did not come from more tools, it came from better sequencing, clearer focus, and tighter alignment to revenue metrics.

What NOT to Do in the First 90 Days

Of course, even disciplined organizations can fall into predictable traps. To avoid ending up with a long list of disconnected AI experiments and a lack of measurement and ROI clarity:

  • Don’t Skip Workflow Mapping: AI won’t solve structural gaps and inconsistent processes, it will magnify the problems.
  • Don’t Overspend Early: Investing heavily in fancy tools and rushed pilots won’t speed up results. High-performing companies align their AI investments with readiness.
  • Don’t Try to Do Too Much: Deploying multiple pilots at once, or “mile wide, inch deep” pilots that touch too many business areas, detracts from focus and diminishes results.
  • Don’t Assume More Investment = More Impact: Commercial AI ROI does not scale linearly with spend
  • Don’t Let Tool Sprawl Drive Strategy: With 13,000+ commercial tools available, undisciplined adoption creates drag, not lift

How Private Equity Operating Partners and CEOs Can Maximize Commercial AI ROI in the First 90 Days

In private equity portfolio companies and mid-market commercial organizations, the first 90 days determine whether Commercial AI becomes a durable value-creation lever or an unfocused experiment.

Shifting away from costly experimentation across the commercial organization, sequenced executional AI initiatives are anchored to a clearly defined bottleneck and an enterprise-value metric tied directly to underwriting assumptions — win rate improvement, retention lift, margin realization, or sales productivity gains.

For portfolio leaders, this structured Commercial AI sequencing:

  • Prevents premature technology spend
  • Limits pilot risk and business disruption
  • Builds early AI proof points
  • Protects capital
  • Accelerates compounding ROI
  • Preserves company credibility

A successful Commercial AI pilot in one portfolio company can serve as a positive inspiration for AI sequencing and processes in others. However, Private Equity Operating Partners should be mindful not to try to force standardization of tools across portfolio companies. Commercial engines differ, and there is no universal “killer app” that suits every use case. The use of AI in private equity portfolio companies must reflect each company’s respective workflow maturity and strategic priorities.

When AI investments are tied to workflow redesign, clear ownership, and governance from day one, they transition from innovation experiments to structured, executional revenue and EBITDA drivers.

Evaluate Your Commercial AI Readiness

Most Commercial AI initiatives stall before delivering measurable impact. However, a structured 90-day AI value creation plan can prevent the common pitfalls of fragmented pilots, overspending on tech, and governance breakdowns.

If you’re leading Commercial AI strategy within a portfolio company or scaling organization, the first question is not which tools to buy — it’s whether your commercial system is ready to absorb and institutionalize Commercial AI.

Schedule a Commercial AI strategy session with our Commercial AI team at Blue Ridge Partners to assess your commercial workflows, identify your primary constraints, and define an executional AI roadmap tied to enterprise-value metrics.

April 7, 2026